Greifswald, Germany
Enzymicals AG, operating for nearly 15 years since its founding in 2009, is a key player in the Biotechnology and Health Care sectors. Based in Germany, the company is dedicated to advancing industrial biocatalysis, from initial catalyst lead-finding to process optimization and scale-up.
Their comprehensive offerings support the global industry in transitioning to biologically-inspired production methods through technologies and solutions for implementing biocatalysis on a large scale, ranging from gram to ton-sized operations. This focus on cell-free manufacturing aligns with Enzymicals' commitment to providing greener and safer manufacturing processes.
Beyond biocatalysis, Enzymicals delivers services in enzymology, cloning, and expression services across various hosts like E. coli, Bacillus, and Pichia, along with strain and fermentation development for protein manufacture. Emphasizing high-quality R&D and customer satisfaction, Enzymicals AG epitomizes the potential for innovation and growth within its industries, although it has not reported any recent investments.
